INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "TREATMENT OF MUSCLE DISORDER WITH FOLLICULIN INTERACTING PROTEIN 1 (FNIP1) INHIBITORS AND/OR FOLLICULIN (FLCN) INHIBITORS"

GENEVA, March 10 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2024/044174) for "TREATMENT OF MUSCLE DISORDER WITH FOLLICULIN INTERACTING PROTEIN 1 (FNIP1) INHIBITORS AND/OR FOLLICULIN (FLCN) INHIBITORS" on Aug 28, 2024. With publication no. WO/2025/049568, the details related to the patent application was published on Mar 06, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LOTTA, Luca Andrea (777 Old Saw Mill River RoadTarrytown, New York 10591), HINDY, George (777 Old Saw Mill River RoadTarrytown, New York 10591)...